Diane Jorkasky
CIK: 0001527204
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Altimmune, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 1, 2026ALT
Altimmune, Inc.
Award(A)DirectStock Options (option to buy)
48.8K shares- - Dec 29, 2025ALT
Altimmune, Inc.
Purchase(P)Direct527 shares at avg. $3.80$2K - Sep 25, 2025ALT
Altimmune, Inc.
Award(A)DirectStock Options (option to buy)
48.8K shares- - Sep 26, 2024ALT
Altimmune, Inc.
Award(A)DirectStock Options (option to buy)
34.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 1, 2026 | ALT Altimmune, Inc. | Award(A) Stock Options (option to buy) | 48,800 | - | - | Direct |
| Dec 29, 2025 | ALT Altimmune, Inc. | Purchase(P) | 527 | $3.80 | $2,003 | Direct |
| Sep 25, 2025 | ALT Altimmune, Inc. | Award(A) Stock Options (option to buy) | 48,800 | - | - | Direct |
| Sep 26, 2024 | ALT Altimmune, Inc. | Award(A) Stock Options (option to buy) | 34,900 | - | - | Direct |
1-4 of 4 transactions
About Jorkasky Diane
Jorkasky Diane (SEC CIK 0001527204) files insider reports with the SEC as Director of Altimmune, Inc. (ALT).
Signal8 holds 4 ownership filings by Jorkasky Diane, all Form 4s, filed between Sep 30, 2024 and May 1, 2026. Those filings report 4 transactions, from Sep 26, 2024 to May 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Jorkasky Diane's filings is in GAITHERSBURG, MD.
Recent filings by Jorkasky Diane
Other insiders filing for Altimmune, Inc. (ALT)
- Arbet-Engels Christophe, Chief Medical Officer
- WEAVER GREGORY L, Chief Financial Officer
- MENZIUSO RICHARD THOMAS, Principal Accounting Officer
- Richardson Linda M, Chief Commercial Officer
- Durso Jerome Benedict, President and CEO
- Roberts M Scot, Chief Scientific Officer